Unity Biotechnology has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. No pricing details were given in the filing, but the offering is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback